Chemotherapy regimens are often identified with acronyms, identifying the agents used in combination. Unfortunately, the letters used are not consistent across regimens, and in some cases (for example, "BEACOPP") the same letter is used to represent two different treatments. Because of this, there is not a naming standard for chemotherapy regimens, and this page merely represents commonly used conventions.
Additional recommended knowledge
The term "Induction regimens" refers to a chemotherapy regimen which is used for the initial treatment of a disease.
| Name | Components | Example of uses, and other notes
|
| ABVD
| Adriamycin, bleomycin, vinblastine, dacarbazine
| Hodgkin's lymphoma
|
| AC
| Adriamycin/Doxorubicin, Cyclophosphamide
| Breast cancer
|
| BEACOPP
| Bleomycin, etoposide, Adriamycin (doxorubicin), cyclophosphamide, Oncovin (vincristine), procarbazine, prednisone
| Hodgkin's lymphoma
|
| BEP
| Bleomycin, etoposide, platinum (cisplatin)
| Testicular cancer, germ cell tumors
|
| CAF
| Cyclophosphamide, Adriamycin/Doxorubicin, 5-FU/Fluorouracil
| Breast cancer
|
| CAV
| Cyclophosphamide, Adriamycin/Doxorubicin, Vincristine
| Lung cancer
|
| CBV
| Cyclophosphamide, BCNU (Carmustine), VP-16 (etoposide)
| Lymphoma
|
| CHOP
| Cyclophosphamide, doxorubicin (hydroxydoxorubicin), vincristine (Oncovin), prednisone
| Non-Hodgkin lymphoma
|
| CHOP-R or R-CHOP
| CHOP + rituximab
| B cell non-Hodgkin lymphoma
|
| COP or CVP
| Cyclophosphamide, vincristine (Oncovin), and prednisone
| Non-Hodgkin lymphoma in patients with history of cardiovascular disease
|
| CMF
| Cyclophosphamide, Methotrexate, and 5-Fluorouracil
| Breast Cancer
|
| COPP
| Cyclophosphamide, Oncovin (vincristine), procarbazine and prednisone
| Non-Hodgkin lymphoma
|
| EC
| Epirubicin, Cyclophosphamide
| Breast cancer
|
| ECF
| Epirubicin, cisplatin, fluorouracil
| Gastric cancer and oesophageal cancer
|
| FOLFOX
| Fluorouracil, leucovorin (folinic acid), and oxaliplatin
| Colorectal cancer
|
| m-BACOD
| Methotrexate, bleomycin, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin), dexamethasone (Decadron)
| Non-Hodgkin lymphoma
|
| MACOP-B
| Methotrexate, leucovorin, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin), prednisone, bleomycin
| Non-Hodgkin lymphoma
|
| MOPP
| Mechlorethamine, vincristine (oncovin), procarbazine, prednisone
| Hodgkin's lymphoma
|
| PCV
| Procarbazine, lomustine (CCNU), vincristine
| Brain tumors
|
| ProMACE-MOPP
| Methotrexate, doxorubicin (Adriamycin), cyclophosphamide, etoposide + MOPP
| Non-Hodgkin lymphoma
|
| ProMACE-CytaBOM
| Prednisone, doxorubicin (adriamycin), cyclophosphamide, etoposide, cytarabine, bleomycin, vincristine (Oncovin), methotrexate, leucovorin
| Non-Hodgkin lymphoma
|
| R-FCM
| Rituximab, fludarabine, cyclophosphamide, mitoxantrone
| B cell non-Hodgkin lymphoma
|
| Stanford V
| Doxorubicin (Adriamycin), mechlorethamine, bleomycin, vinblastine, vincristine (Oncovin), etoposide (VP-16), prednisone
| Hodgkin's lymphoma
|
| Thal/Dex
| Thalidomide, dexamethasone
| Multiple myeloma
|
| VAD
| Vincristine, Adriamycin (doxorubicin), dexamethasone
| Multiple myeloma
|
See also
| Chemotherapeutic agents/Antineoplastic agents (L01) |
|---|
| Alkylating and alkylating-like agents | Nitrogen mustards: (Chlorambucil, Chlormethine, Cyclophosphamide, Ifosfamide, Melphalan). Nitrosoureas:(Carmustine, Fotemustine, Lomustine, Streptozocin). Platinum (alkylating-like): (Carboplatin, Cisplatin, Oxaliplatin, BBR3464). Busulfan, Dacarbazine, Procarbazine, Temozolomide, ThioTEPA, Uramustine |
|---|
| Antimetabolites | Folic acid: (Aminopterin, Methotrexate, Pemetrexed, Raltitrexed). Purine:(Cladribine, Clofarabine, Fludarabine, Mercaptopurine, Pentostatin, Thioguanine). Pyrimidine:(Capecitabine, Cytarabine, Fluorouracil, Floxuridine, Gemcitabine) |
|---|
| Spindle poison/mitotic inhibitor | Taxane: (Docetaxel, Paclitaxel). Vinca: (Vinblastine, Vincristine, Vindesine, Vinorelbine). |
|---|
| Cytotoxic/antitumor antibiotics | Anthracycline family: (Daunorubicin, Doxorubicin, Epirubicin, Idarubicin, Mitoxantrone, Valrubicin) - streptomyces (Actinomycin, Bleomycin, Mitomycin, Plicamycin) - Hydroxyurea |
|---|
| Topoisomerase inhibitors | Camptotheca: (Camptothecin, Topotecan, Irinotecan), Podophyllum:(Etoposide, Teniposide) |
|---|
| CI monoclonal antibodies | Receptor tyrosine kinase (Cetuximab, Panitumumab, Trastuzumab) - CD20 (Rituximab, Tositumomab) - other (Alemtuzumab, Bevacizumab, Gemtuzumab) |
|---|
| Photosensitizers | Aminolevulinic acid, Methyl aminolevulinate, Porfimer sodium, Verteporfin |
|---|
| Tyrosine kinase inhibitors | Dasatinib, Erlotinib, Gefitinib, Imatinib, Lapatinib, Nilotinib, Sorafenib, Sunitinib |
|---|
| Other | retinoids (Alitretinoin, Tretinoin) - Altretamine, Amsacrine, Anagrelide, Arsenic trioxide, Asparaginase (Pegaspargase), Bexarotene, Bortezomib, Denileukin diftitox, Estramustine, Ixabepilone, Masoprocol, Mitotane |
|---|
|
